Document is current
Any future updates will be listed below
-
Authors
Wang, Sheng https://orcid.org/0000-0002-5718-7529
Pisco, Angela Oliveira https://orcid.org/0000-0003-0142-2355
McGeever, Aaron
Brbic, Maria https://orcid.org/0000-0002-1120-1778
Zitnik, Marinka
Darmanis, Spyros
Leskovec, Jure https://orcid.org/0000-0002-5411-923X
Karkanias, Jim
Altman, Russ B. https://orcid.org/0000-0003-3859-2905
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (GM102365)
- License Information
-
More Information
Article History
Received: 7 March 2021
Accepted: 17 August 2021
First Online: 21 September 2021
Competing interests
: R.B.A. declares the following competing interests: stock or other ownership (Personalis, 23andme); consulting or advisory role (United Health, Second Genome, Karius, UK Biobank, Swiss Personalized Health Network, Danish National Genome Center, All of Us Project, and Bridge Bio).
